ArticleAnnals of neurology2026
Daily-Life, Sensor-Derived Tremor Measures Are Sensitive to Progression in Early Parkinson's Disease.
Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSensitive outcome measures are critical for evaluating the efficacy of novel treatments for Parkinson's disease (PD). In this study, we assess the sensitivity to change of sensor-derived daily-life tremor measures over 2 years in unmedicated and medicated persons with early PD.
methodsWe used 2-year continuous wrist sensor data (median wear time: 22 hours/day) from the Personalized Parkinson Project (n = 462 medicated; n = 78 unmedicated at baseline), in combination with annual clinical evaluations of tremor severity. From the gyroscope data, we derived previously validated weekly measures for tremor time and power, which were smoothed over time using piecewise linear trend estimation. One- and 2-year standardized response means (SRMs) were computed to compare the sensitivity to change between the sensor-derived tremor measures and clinical tremor scores.
resultsIn unmedicated participants with tremor, sensor-derived tremor measures demonstrated a high sensitivity to progression (2-year SRMs ranged from 0.67 to 1.09), which was significantly larger than clinical tremor scores (2-year SRMs ranged from 0.21 to 0.41). In medicated participants, sensor-derived tremor time decreased (2-year SRM of -0.18), which was associated with both an increase in dopaminergic medication dose and higher disease duration. In contrast, the sensor-derived tremor power measures and clinical rest tremor scores (measured in the OFF state) increased slightly (2-year SRMs ranging from 0.11 to 0.27).
interpretationBefore initiation of symptomatic treatment, sensor-derived daily-life tremor measures are substantially more sensitive to progression than clinical tremor scores, making them a promising tool to evaluate the efficacy of disease-modifying treatments in early PD. ANN NEUROL 2026;100:282-294.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.